BioStem Technologies Announces Record Preliminary Fourth Quarter Net Revenue of $102.9 Million, with Full-Year 2024 Net Revenue Expected to Reach $301.8 Million
13. Januar 2025 07:00 ET
|
BioStem Technologies, Inc.
BioStem Technologies Announces Record Preliminary Fourth Quarter Net Revenue of $102.9 Million, with Full-Year 2024 Net Revenue Expected to Reach $301.8 M
BioStem Technologies Launches Clinical Trial to Demonstrate the Therapeutic Benefits of its BioREtain® Technology in Treating Diabetic Foot Ulcers Using Vendaje®
08. Januar 2025 07:00 ET
|
BioStem Technologies, Inc.
BioStem Technologies Launches Clinical Trial to Demonstrate the Therapeutic Benefits of its BioREtain® Technology
Advanced Wound Care Management Market Expected To Reach USD 16.40 Billion by 2032, with a CAGR of 4.77% | Introspective Market Research
07. Januar 2025 08:00 ET
|
Introspective Market Research
Dublin, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Introspective Market Research is excited to announce the release of its newest report, "Advanced Wound Care Management Market." This comprehensive analysis...
BioStem Technologies CEO to Present at Biotech Showcase 2025
02. Januar 2025 07:00 ET
|
BioStem Technologies, Inc.
BioStem Technologies CEO to Present at Biotech Showcase 2025
Global Wound Care Market to Reach USD 33.99 Billion by 2032, Driven by Technological Advancements and Growing Chronic Conditions, Reports SNS Insider – SNS Insider
16. Dezember 2024 10:13 ET
|
SNS Insider pvt ltd
Austin, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Wound Care Market Size & Growth Analysis: “According to SNS Insider, the Wound Care Market size was valued at USD 21.8 billion in 2023 and is projected...
BioStem Announces Notice of Allowance for U.S. Patent Application for Sterile Human Placental Allografts
25. November 2024 07:00 ET
|
BioStem Technologies, Inc.
BioStem Announces Notice of Allowance for U.S. Patent Application for Sterile Human Placental Allografts
BioStem Technologies Signs Letter of Intent to Acquire Wound Care Products and Technologies from ProgenaCare Global
20. November 2024 07:00 ET
|
BioStem Technologies, Inc.
BioStem Technologies Signs Letter of Intent to Acquire Wound Care Products and Technologies from ProgenaCare Global
AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand
12. November 2024 16:03 ET
|
AVITA Medical
AVITA Medical announces exclusive distribution agreement to expand the RECELL product platform to Australia and New Zealand.
BioStem Technologies Reports Record Third Quarter 2024 Revenue of $82.6 Million
12. November 2024 07:29 ET
|
BioStem Technologies, Inc.
BioStem Technologies Reports Record Third Quarter 2024 Revenue of $82.6 Million
BioStem Technologies Initiates Nationwide Launch of Vendaje AC® with Venture Medical Following Established Reimbursement in All Medicare Administrative Contractor (MAC) Regions
29. Oktober 2024 07:00 ET
|
BioStem Technologies, Inc.
BioStem Technologies Initiates Nationwide Launch of Vendaje AC® with Venture Medical Following Established Reimbursement in All MAC Regions